Prohibits health benefit plans from requiring enrollee to incur costs over $35 for each 30-day supply of insulin prescribed for diabetes, or $105 for each 90-day supply.
Prohibits Health Evidence Review Commission (HERC) from relying upon any QALY measure in determining coverage of services by the Oregon Health Plan (OHP).
Legislative History
On Feb. 5, 2024, bill was introduced in Senate; on Feb. 13, 2024, bill passed Senate.
On Feb. 14, 2024, bill introduced in the House; on Feb. 27, 2024, bill passed in House.
Effectiveness
Act takes effect on Jan. 1 of year after its passage; amendments re insulin apply to health benefit plans issued, renewed, extended on or after effective date of this act.
Mar. 2024 ORE LEG Governor Approval
On Mar. 25, 2024, ORE LEG reported that bill SB 1508 was approved by governor on Mar. 20, 2024, and assigned Chapter 18; becomes effective as of Jan. 1, 2025.
Document dated Mar. 25, 2024, was received on Apr. 16, due to a fixed feed.
Regulators
ORE LEG
Entity Types
Ins
Reference
Ch. 18, 3/25/2024; Bill SB 1508, 2/27/2024; Citation: ORE INS 743A; ORE LEG 414;
